Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China flag China · Delayed Price · Currency is CNY
7.72
+0.04 (0.52%)
Feb 3, 2026, 3:04 PM CST

SHE:000952 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
259.09307.18415.24431.35293.33350.31
Cash & Short-Term Investments
259.09307.18415.24431.35293.33350.31
Cash Growth
-39.25%-26.02%-3.74%47.05%-16.26%77.44%
Accounts Receivable
177.09223.19297.42294.62197.61147.31
Other Receivables
8.986.646.08-0.550.26
Receivables
186.07229.83303.51299.7203.33161.03
Inventory
317.35322.03298.99221.47164.83163.57
Other Current Assets
59.3561.7866.9352.9747.4727.17
Total Current Assets
821.86920.821,0851,005708.96702.08
Property, Plant & Equipment
1,4641,5771,6371,1991,0691,042
Long-Term Investments
54.547.2835.244.1339.7922.64
Other Intangible Assets
205.27239.62216.91150.62154.72161.57
Long-Term Deferred Tax Assets
20.620.7315.8827.7324.8121.76
Long-Term Deferred Charges
5.239.1210.150.58-0.12
Other Long-Term Assets
9.0418.8230.1342.2551.4329.36
Total Assets
2,5802,7943,0302,4702,0491,979
Accounts Payable
118.33121.22143.02178.6121.62139.1
Accrued Expenses
21.1233.6733.5432.2436.9442.52
Short-Term Debt
468.69344.24291.06197.13241.71207.22
Current Portion of Long-Term Debt
-132.8161.5158.9199.6115.81
Current Portion of Leases
-1.051.591.20.84-
Current Income Taxes Payable
11.220.370.221.852.617.59
Current Unearned Revenue
10.556.47.075.4912.1319.87
Other Current Liabilities
595.32287.77227.8778.6124.8228.33
Total Current Liabilities
1,225927.51865.87654.03540.29460.43
Long-Term Debt
272.84393.75417.29301.5634.45124.43
Long-Term Leases
1.091.352.253.191.65-
Long-Term Unearned Revenue
13.1913.315.6518.1221.0423.29
Long-Term Deferred Tax Liabilities
0.410.50.690.920.33-
Other Long-Term Liabilities
104.36380.96335.320.340.335.6
Total Liabilities
1,6171,7171,637978.17598.09613.75
Common Stock
346.75349.86353.86353.97344347
Additional Paid-In Capital
365.42377.12391.79391.09353.92380.94
Retained Earnings
260.97358.27653.56793.8764.58675.12
Treasury Stock
-9.89-21.23-35.75-36.19--30
Comprehensive Income & Other
2.190.93-0.01-0.02-0.030.02
Total Common Equity
965.431,0651,3631,5031,4621,373
Minority Interest
-2.2311.2629-10.83-11.67-7.39
Shareholders' Equity
963.21,0761,3921,4921,4511,366
Total Liabilities & Equity
2,5802,7943,0302,4702,0491,979
Total Debt
742.62873.19873.69662378.26347.46
Net Cash (Debt)
-483.53-566.01-458.45-230.65-84.932.84
Net Cash Per Share
-1.39-1.61-1.30-0.65-0.250.01
Filing Date Shares Outstanding
346.75349.86353.86353.97344344
Total Common Shares Outstanding
346.75349.86353.86353.97344344
Working Capital
-403.36-6.69218.8351.46168.67241.65
Book Value Per Share
2.783.043.854.254.253.99
Tangible Book Value
760.16825.321,1471,3521,3081,212
Tangible Book Value Per Share
2.192.363.243.823.803.52
Buildings
-1,1631,196899.49839.29795.03
Machinery
-1,4561,370942.21840.98816.55
Construction In Progress
-33.160.96258.14204.47166.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.